Australasian COVID-19 Trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

Trial Overview

753 patients enrolled in trial

753 patients randomised

23 sites activated

News

View all

The ASCOT Process

01. Identify potential treatment options

02. Evaluate candidate treatments

03. Identify effective treatments & disregard ineffective treatments

04. Generate clinical evidence that can be applied during the pandemic and within the trial itself